
Lilian Anekwe has been named as the new editor for the Pharmafocus and Pharmafile brands, and joins the publishing team …

The EU’s Innovative Medicines Initiative (IMI) has unveiled a new programme to find vaccines, drugs and diagnostics for Ebola, funded …

A report has suggested the National Health Service could make nearly £2 billion in cost savings if doctors ‘provided more …

In a deal worth $4.5 billion Perrigo has announced the acquisition of over-the-counter (OTC) drugmaker Omega. This places the Irish …
“Translation is that which transforms everything so that nothing changes.” Günter Grass The art of a good translation is to …
UK healthcare agency MJL has made two appointments in Nina Buckley as managing director and Nicky Oates as a senior …
To help customers better understand SHL products and services, a suite of communication tools including articles, white papers, case studies, …

A cheap iPhone app developed last year has demonstrated high-level effectiveness towards identifying bogus antimalarial treatments. A recent study published …
Lundbeck’s sales fell dramatically in the third quarter of 2014 as it struggles with expiring patents, although several of its …

Allergan’s efforts to block a key supporter of Valeant’s hostile takeover bid from voting at next month’s special shareholder meeting …

The interest in mobile health (mHealth) wearables is gaining traction, but consumers want more affordable devices that offer greater engagement …

Roche has said it will invest 450 million Swiss francs ($468m) in the construction of a diagnostics manufacturing facility in …

ROCK medical communications has appointed Terence Bradley to be its managing director. Most recently Bradley was the founding director of …

The ABPI has appointed a new director of communications in Aileen Thompson, a former Vodaphone head who replaces Catherine Meadon in …

The state of cancer services in Wales has come under increased scrutiny this week as the country’s ability to provide …

A group of oesophageal cancer patients can increase their survival by six months or more if treated with AstraZeneca’s Iressa, …

US medical diagnostics firm LabCorp has entered the drug development business via a $6.1 billion deal to buy contract research …

Cambridge-based genetics research firm Horizon Discovery has appointed Dr David Smoller to be an executive director on its board. Smoller …

AstraZeneca has strengthened its oncology capabilities with the acquisition of Definiens, a German company that has pioneered cancer imaging and …
Astellas has announced it will collaborate with Proteostasis Therapeutics to develop drugs for diseases caused by protein defects, using the …